Serum levels of VEGF and MMP-9 were closely associated with tumor size (P<0.001), and the serum levels in patients with stage III or IV breast cancer were significantly higher than those classified as TNM stage I or II (P<0.001). Here, MMP9 is linked to breast carcinoma.